Kiniksa (KNSA) PT Raised to $38 at Wedbush, Following RHAPSODY Drug Trial Results Released

June 29, 2020 10:48 AM EDT
Get Alerts KNSA Hot Sheet
Price: $11.61 -1.78%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 13 | New: 22
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten raised the price target on Kiniksa (NASDAQ: KNSA) to $38.00 (from $30.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change